Bio-Rad Laboratories, Inc. (BIO)
Largest Insider Buys in Sector
BIO Stock Price History Chart
BIO Stock Performance
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, …
Insider Activity of Bio-Rad Laboratories, Inc.
Over the last 12 months, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $554,866 worth of Bio-Rad Laboratories, Inc. stock.
On average, over the past 5 years, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $5.18M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $109,792 was made by HINCKLEY GREGORY K (director) on 2017‑05‑26.
List of Insider Buy and Sell Transactions, Bio-Rad Laboratories, Inc.
| 2023-12-12 | Sale | EVP, President, CDG | 1,200 0.0042% | $299.16 | $358,992 | +8.88% | ||
| 2023-11-28 | Sale | EVP, GBL Commercial Operations | 642 0.0022% | $305.10 | $195,874 | +5.36% | ||
| 2023-08-30 | Sale | EVP, General Counsel & Sec | 2,350 0.0081% | $395.60 | $929,667 | -20.17% | ||
| 2023-08-23 | Sale | EVP, General Counsel & Sec | 300 0.001% | $384.69 | $115,407 | -17.82% | ||
| 2023-06-15 | Sale | EVP, GBL Commercial Operations | 500 0.0017% | $379.39 | $189,695 | -13.92% | ||
| 2023-06-06 | Sale | SVP, Chief Accounting Officer | 198.35 0.0007% | $368.30 | $73,053 | -11.34% | ||
| 2023-03-08 | Sale | EVP, General Counsel & Sec | 1,746 0.006% | $486.43 | $849,300 | -24.18% | ||
| 2022-11-10 | Sale | SVP, Chief Accounting Officer | 379.38 0.0013% | $421.87 | $160,051 | -6.43% | ||
| 2022-08-05 | Sale | SVP, Chief Accounting Officer | 518 0.0017% | $537.00 | $278,166 | -21.06% | ||
| 2021-11-12 | Sale | Executive Vice President | 4,800 0.016% | $750.05 | $3.6M | -29.26% | ||
| 2021-11-11 | Sale | Executive Vice President | 1,546 0.0052% | $749.00 | $1.16M | -28.86% | ||
| 2021-09-03 | Sale | EVP, Chief Financial Officer | 270 0.0009% | $820.06 | $221,416 | -28.93% | ||
| 2021-09-02 | Sale | EVP, Chief Financial Officer | 540 0.0018% | $828.00 | $447,121 | -29.43% | ||
| 2021-09-01 | Sale | EVP, Chief Operating Officer | 2,000 0.0067% | $813.10 | $1.63M | -28.42% | ||
| 2021-08-26 | Sale | Executive Vice President | 600 0.002% | $792.58 | $475,548 | -26.32% | ||
| 2021-08-09 | Sale | EVP, GBL Commercial Operations | 3,000 0.01% | $754.93 | $2.26M | -19.26% | ||
| 2021-08-04 | Sale | EVP, General Counsel & Sec | 327 0.0011% | $760.26 | $248,605 | -19.02% | ||
| 2021-08-04 | Sale | EVP, Chief Financial Officer | 2,300 0.0076% | $751.84 | $1.73M | -19.02% | ||
| 2021-02-19 | Sale | EVP, General Counsel & Sec | 923.11 0.0021% | $432.07 | $398,851 | +4.93% | ||
| 2020-12-15 | Sale | EVP, GBL Commercial Operations | 374 0.0012% | $580.67 | $217,171 | +9.55% |
Insider Historical Profitability
| SCHWARTZ ALICE N | director, 10 percent owner | 1806651 6.45% | $372.09 | 1 | 2 | <0.0001% |
| SCHWARTZ DAVID | Chairman of the Board | 8753 0.0312% | $372.09 | 1 | 0 | <0.0001% |
| HUTTON RONALD W | Vice President and Treasurer | 4140 0.0148% | $372.09 | 1 | 17 | <0.0001% |
| HINCKLEY GREGORY K | director | 500 0.0018% | $372.09 | 1 | 0 | +11% |
| STARK JAMES R | VP, Corporate Controller | 0 0% | $372.09 | 1 | 27 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $837.47M | 8.49 | 2.42M | +1.32% | +$10.88M | 0.02 | |
| BlackRock | $511.85M | 5.19 | 1.48M | +0.93% | +$4.72M | 0.01 | |
| Veritas Asset Management LLP | $396.75M | 4.02 | 1.15M | +5.93% | +$22.21M | 2.88 | |
| State Street | $302.18M | 3.06 | 873,675 | -0.14% | -$428,532.93 | 0.01 | |
| EARNEST Partners | $178.09M | 1.81 | 514,906 | +30.81% | +$41.94M | 0.82 |